Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:11 am
| PEG Ratio | 5.48 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dalmia Bharat Ltd, a prominent player in the cement industry, reported a stock price of ₹2,147, with a market capitalization of ₹40,272 Cr. The company has shown a steady growth trajectory in its revenue, with reported sales figures rising from ₹11,286 Cr in FY 2022 to ₹13,552 Cr in FY 2023. The latest trailing twelve months (TTM) figure stands at ₹14,325 Cr, indicating a robust operational performance. Quarterly sales figures also reflect this upward trend, with sales reaching ₹3,915 Cr in March 2023, although it witnessed a slight decline to ₹3,153 Cr in September 2023. The company’s sales for the upcoming quarters suggest a potential recovery as it moves into FY 2025, with projected sales of ₹4,091 Cr in March 2025. Dalmia Bharat’s operational strategy appears focused on maintaining its competitive edge within a challenging market environment, characterized by fluctuating demand and rising input costs.
Profitability and Efficiency Metrics
Dalmia Bharat Ltd’s profitability metrics indicate a mixed performance. The operating profit margin (OPM) stood at 20% for the most recent reporting period, reflecting a solid operational efficiency compared to the sector average. However, the OPM has fluctuated throughout the year, peaking at 22% in December 2023 and dipping to 14% in September 2024. The net profit for FY 2023 was reported at ₹1,079 Cr, which declined to ₹699 Cr in FY 2025. The company’s return on equity (ROE) was recorded at 4.15%, while the return on capital employed (ROCE) was 5.58%, both figures indicating challenges in generating shareholder returns compared to industry benchmarks. Interest coverage ratio (ICR) at 6.67x demonstrates a strong ability to cover interest expenses, though this has decreased from previous periods. The cash conversion cycle remains notably efficient at -1 days, highlighting effective management of working capital.
Balance Sheet Strength and Financial Ratios
Dalmia Bharat Ltd’s balance sheet reveals a stable financial position with total borrowings reported at ₹7,082 Cr against reserves of ₹17,641 Cr, providing a healthy buffer. The debt-to-equity ratio stood at 0.30, indicating a conservative leverage strategy compared to sector norms. The company’s book value per share, including revaluation reserves, is ₹914.42, suggesting a solid asset base for equity holders. Key financial ratios such as the current ratio at 1.59 and quick ratio at 1.33 reflect adequate liquidity, although the inventory turnover ratio of 10.74x indicates efficient inventory management practices. Profitability ratios, including net profit margin at 5.00% and return on assets at 2.25%, reveal room for improvement in converting sales into profits. The reported enterprise value stands at ₹39,795.55 Cr, aligning with industry standards while showing potential for value creation.
Shareholding Pattern and Investor Confidence
The shareholding structure of Dalmia Bharat Ltd reflects a stable ownership base, with promoters holding 55.84% of the equity. The foreign institutional investors (FIIs) have gradually decreased their stake from 12.43% in December 2022 to 8.75% by September 2025, indicating a cautious outlook from foreign investors. Domestic institutional investors (DIIs) have increased their holdings, rising from 8.13% in December 2022 to 17.81% in September 2025, showcasing growing confidence among local investors. The public shareholding has decreased to 17.45%, which may signal a consolidation of ownership among institutional investors. The total number of shareholders has also declined over the past year, standing at 75,971, which could be indicative of market consolidation trends or investor sentiment shifts. Overall, the ownership dynamics suggest a mix of confidence and caution among investors regarding the company’s future prospects.
Outlook, Risks, and Final Insight
Dalmia Bharat Ltd’s future outlook remains contingent on several factors. The anticipated recovery in sales and operational efficiency could enhance profitability, especially if the company successfully navigates input cost inflation and competitive pressures. However, risks such as fluctuating demand in the cement sector and potential regulatory hurdles could pose challenges. The company’s financial health, underscored by its strong balance sheet and efficient working capital management, positions it well to withstand economic headwinds. Strengths include a solid operational framework evidenced by a robust OPM and a conservative debt profile, while risks include declining net profit margins and reduced FII interest. In scenarios where demand surges or input costs stabilize, Dalmia Bharat could see significant growth; conversely, continued market volatility may hinder its recovery trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.9/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,50,639 Cr. | 11,899 | 13,102/10,048 | 47.8 | 2,444 | 0.65 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 24,969 Cr. | 1,057 | 1,209/788 | 129 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,803 Cr. | 445 | 451/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,993 Cr. | 223 | 309/196 | 29.7 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 36,832.70 Cr | 1,936.30 | 37.85 | 573.47 | 0.53% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,971 | 3,355 | 3,915 | 3,627 | 3,153 | 3,604 | 4,307 | 3,621 | 3,087 | 3,181 | 4,091 | 3,636 | 3,417 |
| Expenses | 2,592 | 2,711 | 3,205 | 3,014 | 2,560 | 2,825 | 3,653 | 2,952 | 2,653 | 2,670 | 3,298 | 2,753 | 2,721 |
| Operating Profit | 379 | 644 | 710 | 613 | 593 | 779 | 654 | 669 | 434 | 511 | 793 | 883 | 696 |
| OPM % | 13% | 19% | 18% | 17% | 19% | 22% | 15% | 18% | 14% | 16% | 19% | 24% | 20% |
| Other Income | 33 | 42 | 424 | 54 | 80 | 60 | 120 | -63 | 73 | 37 | 93 | 65 | 66 |
| Interest | 54 | 69 | 64 | 83 | 101 | 108 | 94 | 95 | 98 | 101 | 105 | 108 | 122 |
| Depreciation | 332 | 325 | 336 | 399 | 401 | 370 | 328 | 317 | 336 | 364 | 314 | 322 | 322 |
| Profit before tax | 26 | 292 | 734 | 185 | 171 | 361 | 352 | 194 | 73 | 83 | 467 | 518 | 318 |
| Tax % | -81% | 25% | 17% | 22% | 28% | 26% | 9% | 25% | 33% | 20% | 6% | 24% | 25% |
| Net Profit | 47 | 218 | 609 | 144 | 123 | 266 | 320 | 145 | 49 | 66 | 439 | 395 | 239 |
| EPS in Rs | 2.45 | 10.88 | 31.42 | 6.93 | 6.29 | 14.02 | 16.80 | 7.52 | 2.45 | 3.25 | 23.19 | 20.95 | 12.58 |
Last Updated: January 2, 2026, 12:35 am
Below is a detailed analysis of the quarterly data for Dalmia Bharat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,636.00 Cr. (Jun 2025) to 3,417.00 Cr., marking a decrease of 219.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,721.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,753.00 Cr. (Jun 2025) to 2,721.00 Cr., marking a decrease of 32.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 696.00 Cr.. The value appears to be declining and may need further review. It has decreased from 883.00 Cr. (Jun 2025) to 696.00 Cr., marking a decrease of 187.00 Cr..
- For OPM %, as of Sep 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Jun 2025) to 20.00%, marking a decrease of 4.00%.
- For Other Income, as of Sep 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Jun 2025) to 66.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 122.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.00 Cr. (Jun 2025) to 122.00 Cr., marking an increase of 14.00 Cr..
- For Depreciation, as of Sep 2025, the value is 322.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 322.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 318.00 Cr.. The value appears to be declining and may need further review. It has decreased from 518.00 Cr. (Jun 2025) to 318.00 Cr., marking a decrease of 200.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Jun 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 395.00 Cr. (Jun 2025) to 239.00 Cr., marking a decrease of 156.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 12.58. The value appears to be declining and may need further review. It has decreased from 20.95 (Jun 2025) to 12.58, marking a decrease of 8.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:28 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,444 | 8,579 | 9,484 | 9,674 | 10,110 | 11,286 | 13,552 | 14,691 | 13,980 | 14,325 |
| Expenses | 5,550 | 6,543 | 7,542 | 7,591 | 7,340 | 8,860 | 11,224 | 12,052 | 11,573 | 11,442 |
| Operating Profit | 1,894 | 2,036 | 1,942 | 2,083 | 2,770 | 2,426 | 2,328 | 2,639 | 2,407 | 2,883 |
| OPM % | 25% | 24% | 20% | 22% | 27% | 22% | 17% | 18% | 17% | 20% |
| Other Income | 296 | 274 | 235 | 217 | 145 | 171 | 532 | 314 | 140 | 261 |
| Interest | 856 | 708 | 542 | 415 | 303 | 202 | 234 | 386 | 399 | 436 |
| Depreciation | 1,226 | 1,213 | 1,296 | 1,528 | 1,250 | 1,235 | 1,305 | 1,498 | 1,331 | 1,322 |
| Profit before tax | 108 | 389 | 339 | 357 | 1,362 | 1,160 | 1,321 | 1,069 | 817 | 1,386 |
| Tax % | 69% | 25% | -3% | 33% | 13% | 27% | 18% | 20% | 14% | |
| Net Profit | 44 | 291 | 349 | 238 | 1,183 | 845 | 1,079 | 853 | 699 | 1,139 |
| EPS in Rs | 8,800.00 | 58,400.00 | 15.96 | 11.61 | 62.58 | 43.55 | 55.21 | 44.04 | 36.41 | 59.97 |
| Dividend Payout % | 0% | 1,937% | 13% | 17% | 2% | 20% | 16% | 21% | 25% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 561.36% | 19.93% | -31.81% | 397.06% | -28.57% | 27.69% | -20.95% | -18.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | -541.43% | -51.74% | 428.86% | -425.63% | 56.26% | -48.64% | 2.89% |
Dalmia Bharat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 7% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | -2% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 16% |
| 1 Year: | 25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 2:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:08 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6,654 | 6,654 | 39 | 39 | 37 | 37 | 37 | 38 | 38 | 38 |
| Reserves | 2,975 | 3,681 | 10,600 | 10,522 | 12,773 | 16,024 | 15,591 | 16,359 | 17,336 | 17,641 |
| Borrowings | 8,038 | 7,266 | 5,883 | 6,049 | 3,839 | 3,176 | 3,855 | 4,805 | 5,702 | 7,082 |
| Other Liabilities | 3,595 | 3,763 | 4,016 | 4,268 | 5,237 | 5,431 | 6,036 | 6,510 | 7,095 | 6,752 |
| Total Liabilities | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 30,171 | 31,513 |
| Fixed Assets | 15,516 | 14,037 | 13,573 | 12,555 | 13,626 | 14,147 | 14,784 | 15,732 | 17,306 | 17,298 |
| CWIP | 128 | 168 | 520 | 1,740 | 1,006 | 1,034 | 1,871 | 2,395 | 2,616 | 3,488 |
| Investments | 2,740 | 3,505 | 2,424 | 2,816 | 4,033 | 5,704 | 3,524 | 4,462 | 5,119 | 5,597 |
| Other Assets | 2,878 | 3,654 | 4,021 | 3,767 | 3,221 | 3,783 | 5,340 | 5,123 | 5,130 | 5,130 |
| Total Assets | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 30,171 | 31,513 |
Below is a detailed analysis of the balance sheet data for Dalmia Bharat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Reserves, as of Sep 2025, the value is 17,641.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,336.00 Cr. (Mar 2025) to 17,641.00 Cr., marking an increase of 305.00 Cr..
- For Borrowings, as of Sep 2025, the value is 7,082.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5,702.00 Cr. (Mar 2025) to 7,082.00 Cr., marking an increase of 1,380.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6,752.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,095.00 Cr. (Mar 2025) to 6,752.00 Cr., marking a decrease of 343.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 31,513.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30,171.00 Cr. (Mar 2025) to 31,513.00 Cr., marking an increase of 1,342.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 17,298.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17,306.00 Cr. (Mar 2025) to 17,298.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 3,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 3,488.00 Cr., marking an increase of 872.00 Cr..
- For Investments, as of Sep 2025, the value is 5,597.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,119.00 Cr. (Mar 2025) to 5,597.00 Cr., marking an increase of 478.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5,130.00 Cr..
- For Total Assets, as of Sep 2025, the value is 31,513.00 Cr.. The value appears strong and on an upward trend. It has increased from 30,171.00 Cr. (Mar 2025) to 31,513.00 Cr., marking an increase of 1,342.00 Cr..
Notably, the Reserves (17,641.00 Cr.) exceed the Borrowings (7,082.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -5.00 | -4.00 | -4.00 | -1.00 | -1.00 | -1.00 | -2.00 | -3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 24 | 21 | 25 | 18 | 22 | 19 | 21 | 23 |
| Inventory Days | 189 | 186 | 211 | 204 | 180 | 234 | 242 | 164 | 217 |
| Days Payable | 258 | 223 | 179 | 173 | 213 | 211 | 209 | 178 | 241 |
| Cash Conversion Cycle | -43 | -13 | 53 | 55 | -14 | 45 | 52 | 8 | -1 |
| Working Capital Days | -89 | -63 | -60 | -85 | -83 | -60 | -33 | -27 | -39 |
| ROCE % | 6% | 4% | 4% | 10% | 7% | 8% | 7% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 4,239,390 | 1.41 | 851.86 | 3,903,665 | 2025-12-15 01:04:20 | 8.6% |
| SBI Multicap Fund | 3,146,675 | 2.64 | 632.29 | N/A | N/A | N/A |
| Mirae Asset Large & Midcap Fund | 2,993,102 | 1.38 | 601.43 | 2,847,156 | 2025-12-15 01:04:20 | 5.13% |
| Kotak Flexicap Fund | 2,700,000 | 0.95 | 542.54 | 2,600,000 | 2025-12-15 01:04:20 | 3.85% |
| Kotak Large & Midcap Fund | 2,225,000 | 1.49 | 447.09 | N/A | N/A | N/A |
| SBI Midcap Fund | 2,050,000 | 1.76 | 411.93 | N/A | N/A | N/A |
| Mirae Asset Midcap Fund | 2,005,166 | 2.19 | 402.92 | 1,772,512 | 2025-12-15 01:04:20 | 13.13% |
| Nippon India Growth Mid Cap Fund | 1,800,000 | 0.86 | 361.69 | N/A | N/A | N/A |
| Kotak Multicap Fund | 1,003,141 | 0.9 | 201.57 | N/A | N/A | N/A |
| UTI Mid Cap Fund | 704,343 | 1.17 | 141.53 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 36.42 | 44.05 | 55.22 | 61.84 | 65.65 |
| Diluted EPS (Rs.) | 36.42 | 44.03 | 55.19 | 61.84 | 65.55 |
| Cash EPS (Rs.) | 106.84 | 123.74 | 98.92 | 129.95 | 135.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 914.42 | 868.79 | 851.03 | 851.84 | 684.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 914.42 | 868.79 | 851.03 | 851.84 | 684.49 |
| Revenue From Operations / Share (Rs.) | 735.79 | 773.21 | 731.89 | 610.05 | 568.76 |
| PBDIT / Share (Rs.) | 140.00 | 155.47 | 132.65 | 139.78 | 160.70 |
| PBIT / Share (Rs.) | 69.95 | 76.63 | 62.11 | 72.97 | 92.49 |
| PBT / Share (Rs.) | 43.00 | 56.32 | 41.68 | 61.95 | 76.11 |
| Net Profit / Share (Rs.) | 36.79 | 44.89 | 28.38 | 63.13 | 67.19 |
| NP After MI And SOA / Share (Rs.) | 35.95 | 43.47 | 55.95 | 61.84 | 66.54 |
| PBDIT Margin (%) | 19.02 | 20.10 | 18.12 | 22.91 | 28.25 |
| PBIT Margin (%) | 9.50 | 9.91 | 8.48 | 11.96 | 16.26 |
| PBT Margin (%) | 5.84 | 7.28 | 5.69 | 10.15 | 13.38 |
| Net Profit Margin (%) | 5.00 | 5.80 | 3.87 | 10.34 | 11.81 |
| NP After MI And SOA Margin (%) | 4.88 | 5.62 | 7.64 | 10.13 | 11.69 |
| Return on Networth / Equity (%) | 3.93 | 5.03 | 6.62 | 7.29 | 9.74 |
| Return on Capital Employeed (%) | 5.31 | 6.25 | 5.44 | 6.71 | 10.15 |
| Return On Assets (%) | 2.25 | 2.97 | 4.05 | 4.59 | 5.64 |
| Long Term Debt / Equity (X) | 0.26 | 0.27 | 0.20 | 0.12 | 0.16 |
| Total Debt / Equity (X) | 0.30 | 0.28 | 0.23 | 0.19 | 0.23 |
| Asset Turnover Ratio (%) | 0.48 | 0.55 | 0.53 | 0.01 | 0.01 |
| Current Ratio (X) | 1.59 | 1.76 | 1.65 | 1.57 | 1.31 |
| Quick Ratio (X) | 1.33 | 1.48 | 1.35 | 1.38 | 1.12 |
| Inventory Turnover Ratio (X) | 10.74 | 4.13 | 4.94 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 24.74 | 20.46 | 16.32 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.39 | 7.27 | 7.22 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 75.26 | 79.54 | 83.68 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.61 | 92.73 | 92.78 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.67 | 7.65 | 10.49 | 12.80 | 9.81 |
| Interest Coverage Ratio (Post Tax) (X) | 3.04 | 3.21 | 3.88 | 6.75 | 5.10 |
| Enterprise Value (Cr.) | 39795.55 | 41059.80 | 39904.23 | 30682.95 | 32013.43 |
| EV / Net Operating Revenue (X) | 2.85 | 2.79 | 2.95 | 2.72 | 3.04 |
| EV / EBITDA (X) | 14.96 | 13.90 | 16.26 | 11.87 | 10.77 |
| MarketCap / Net Operating Revenue (X) | 2.47 | 2.51 | 2.68 | 2.45 | 2.79 |
| Retention Ratios (%) | 75.25 | 79.53 | 83.67 | 0.00 | 0.00 |
| Price / BV (X) | 1.99 | 2.25 | 2.32 | 1.76 | 2.33 |
| Price / Net Operating Revenue (X) | 2.47 | 2.51 | 2.68 | 2.45 | 2.79 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 |
After reviewing the key financial ratios for Dalmia Bharat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 36.42. This value is within the healthy range. It has decreased from 44.05 (Mar 24) to 36.42, marking a decrease of 7.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 36.42. This value is within the healthy range. It has decreased from 44.03 (Mar 24) to 36.42, marking a decrease of 7.61.
- For Cash EPS (Rs.), as of Mar 25, the value is 106.84. This value is within the healthy range. It has decreased from 123.74 (Mar 24) to 106.84, marking a decrease of 16.90.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 914.42. It has increased from 868.79 (Mar 24) to 914.42, marking an increase of 45.63.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 914.42. It has increased from 868.79 (Mar 24) to 914.42, marking an increase of 45.63.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 735.79. It has decreased from 773.21 (Mar 24) to 735.79, marking a decrease of 37.42.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 140.00. This value is within the healthy range. It has decreased from 155.47 (Mar 24) to 140.00, marking a decrease of 15.47.
- For PBIT / Share (Rs.), as of Mar 25, the value is 69.95. This value is within the healthy range. It has decreased from 76.63 (Mar 24) to 69.95, marking a decrease of 6.68.
- For PBT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has decreased from 56.32 (Mar 24) to 43.00, marking a decrease of 13.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 36.79. This value is within the healthy range. It has decreased from 44.89 (Mar 24) to 36.79, marking a decrease of 8.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 35.95. This value is within the healthy range. It has decreased from 43.47 (Mar 24) to 35.95, marking a decrease of 7.52.
- For PBDIT Margin (%), as of Mar 25, the value is 19.02. This value is within the healthy range. It has decreased from 20.10 (Mar 24) to 19.02, marking a decrease of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 9.50. This value is below the healthy minimum of 10. It has decreased from 9.91 (Mar 24) to 9.50, marking a decrease of 0.41.
- For PBT Margin (%), as of Mar 25, the value is 5.84. This value is below the healthy minimum of 10. It has decreased from 7.28 (Mar 24) to 5.84, marking a decrease of 1.44.
- For Net Profit Margin (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 5.80 (Mar 24) to 5.00, marking a decrease of 0.80.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 8. It has decreased from 5.62 (Mar 24) to 4.88, marking a decrease of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.93. This value is below the healthy minimum of 15. It has decreased from 5.03 (Mar 24) to 3.93, marking a decrease of 1.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.31. This value is below the healthy minimum of 10. It has decreased from 6.25 (Mar 24) to 5.31, marking a decrease of 0.94.
- For Return On Assets (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. It has decreased from 2.97 (Mar 24) to 2.25, marking a decrease of 0.72.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.26, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 0.30, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.48. It has decreased from 0.55 (Mar 24) to 0.48, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.76 (Mar 24) to 1.59, marking a decrease of 0.17.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 1.33, marking a decrease of 0.15.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.74. This value exceeds the healthy maximum of 8. It has increased from 4.13 (Mar 24) to 10.74, marking an increase of 6.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 24.74. This value is within the healthy range. It has increased from 20.46 (Mar 24) to 24.74, marking an increase of 4.28.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.39. This value is below the healthy minimum of 20. It has increased from 7.27 (Mar 24) to 8.39, marking an increase of 1.12.
- For Earning Retention Ratio (%), as of Mar 25, the value is 75.26. This value exceeds the healthy maximum of 70. It has decreased from 79.54 (Mar 24) to 75.26, marking a decrease of 4.28.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.61. This value exceeds the healthy maximum of 70. It has decreased from 92.73 (Mar 24) to 91.61, marking a decrease of 1.12.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.67. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 6.67, marking a decrease of 0.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.04. This value is within the healthy range. It has decreased from 3.21 (Mar 24) to 3.04, marking a decrease of 0.17.
- For Enterprise Value (Cr.), as of Mar 25, the value is 39,795.55. It has decreased from 41,059.80 (Mar 24) to 39,795.55, marking a decrease of 1,264.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 2.85, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 14.96. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 14.96, marking an increase of 1.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 2.51 (Mar 24) to 2.47, marking a decrease of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 75.25. This value exceeds the healthy maximum of 70. It has decreased from 79.53 (Mar 24) to 75.25, marking a decrease of 4.28.
- For Price / BV (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.99, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 2.51 (Mar 24) to 2.47, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dalmia Bharat Ltd:
- Net Profit Margin: 5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.31% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.93% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.2 (Industry average Stock P/E: 37.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Dalmiapuram, Lalgudi, Tiruchirapalli Dist. Tamil Nadu 621651 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yadu Hari Dalmia | Chairman & Non-Exe.Director |
| Mr. Gautam Dalmia | Managing Director |
| Mr. Puneet Yadu Dalmia | Managing Director & CEO |
| Dr. Niddodi Subrao Rajan | Non Executive Director |
| Mrs. Anuradha Mookerjee | Ind. Non-Executive Director |
| Mr. Paul Heinz Hugentobler | Ind. Non-Executive Director |
| Mr. Haigreve Khaitan | Ind. Non-Executive Director |
| Mr. Anuj Gulati | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Dalmia Bharat Ltd?
Dalmia Bharat Ltd's intrinsic value (as of 04 January 2026) is ₹1138.10 which is 46.99% lower the current market price of ₹2,147.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹40,272 Cr. market cap, FY2025-2026 high/low of ₹2,496/1,601, reserves of ₹17,641 Cr, and liabilities of ₹31,513 Cr.
What is the Market Cap of Dalmia Bharat Ltd?
The Market Cap of Dalmia Bharat Ltd is 40,272 Cr..
What is the current Stock Price of Dalmia Bharat Ltd as on 04 January 2026?
The current stock price of Dalmia Bharat Ltd as on 04 January 2026 is ₹2,147.
What is the High / Low of Dalmia Bharat Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dalmia Bharat Ltd stocks is ₹2,496/1,601.
What is the Stock P/E of Dalmia Bharat Ltd?
The Stock P/E of Dalmia Bharat Ltd is 36.2.
What is the Book Value of Dalmia Bharat Ltd?
The Book Value of Dalmia Bharat Ltd is 943.
What is the Dividend Yield of Dalmia Bharat Ltd?
The Dividend Yield of Dalmia Bharat Ltd is 0.42 %.
What is the ROCE of Dalmia Bharat Ltd?
The ROCE of Dalmia Bharat Ltd is 5.58 %.
What is the ROE of Dalmia Bharat Ltd?
The ROE of Dalmia Bharat Ltd is 4.15 %.
What is the Face Value of Dalmia Bharat Ltd?
The Face Value of Dalmia Bharat Ltd is 2.00.